Open AccessIntravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
Author(s) -
Nikunj J Shah,
Urmi Shah
Publication year - 2011
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.82005
Subject(s) - medicine , ranibizumab , choroidal neovascularization , ophthalmology , visual acuity , fluorescein angiography , toxoplasmosis , bevacizumab , surgery , chemotherapy , virology
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.